| Authors: |
Roohani S; Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Electronic address: s.roohani@uke.de., Spałek MJ; Department of Radiotherapy I, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Aggerholm-Pedersen N; Department of Oncology, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark., Eckert F; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria., Ashleigh Guadagnolo B; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA., Kirsch DG; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Péchoux CL; Department of Radiation Oncology, Gustave Roussy, Villejuif 94850, France., Miah AB; Department of Radiotherapy and Physics, The Royal Marsden Hospital and The Institute of Cancer Research, London, the United Kingdom of Great Britain and Northern Ireland., Salerno KE; Radiation Oncology Branch, National Cancer Institute, Bethesda, MD, USA., Sangalli C; Department of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Simões R; Department of Radiotherapy and Physics, The Royal Marsden Hospital and The Institute of Cancer Research, London, the United Kingdom of Great Britain and Northern Ireland; Radiotherapy and Proton Beam Therapy Departments, University College London Hospitals NHS Foundation Trust, London NW1 2BU, the United Kingdom of Great Britain and Northern Ireland; UK Radiotherapy Trials Quality Assurance (RTTQA) Group, Radiotherapy Physics, Mount Vernon Cancer Centre, Northwood, the United Kingdom of Great Britain and Northern Ireland., Walter R; Department of Medical Physics, Universitätsklinikum Augsburg, Stenglinstr 2, 86156 Augsburg, Germany., Wiltink LM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, the Netherlands., Zaidi S; Department of Clinical Oncology, The Royal Marsden Hospital and The Institute of Cancer Research, London, the United Kingdom of Great Britain and Northern Ireland., Timmermann B; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Essen, Germany., Haas RL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, the Netherlands. |
